Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin

doi:10.4251/wjgo.v15.i2.286

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4038)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-3) series.

Item

Count

PDF

144

WORD

HTML

1338

Figures (1-8)

388

Tables (1-3)

255

Sum=2159

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

310

Download

818

Sum=1128

Publishing Process of This Article

Item

Count

Browse

191

Download

560

Sum=751

Feb 15, 2023 (publication date) through Feb 11, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Feb 15, 2023; 15(2): 286-302
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.286

Table 3 Univariate and multivariate analyses of progression-free survival in patients with gastric cancer

Prognostic variables	Univariate analysis			Multivariate analysis
Prognostic variables	Hazard ratio	95% confidence interval	P value	Hazard ratio	95% confidence interval	P value
Sex	0.973	0.574–1.650	0.919	-	-	-
Age	1.363	0.814–2.281	0.239	-	-	-
Tumor location	0.913	0.538–1.548	0.735	-	-	-
Histological grade	0.73	0.417–1.278	0.27	-	-	-
Tumor size	2.43	1.407–4.197	0.004^a	0.869	0.504–1.499	0.614
T stage	3.15	1.669–5.943	0.000^a	2.644	1.294–5.420	0.009^a
N stage	2.044	1.202–3.476	0.008^a	1.451	0.728–2.891	0.29
TNM stage	1.917	1.150–3.194	0.013^a	0.88	0.452–1.713	0.88
CIP2A expression	2.309	1.282–3.911	0.003^a	1.821	1.021–3.247	0.042^a

^aP < 0.05.

T: Tumor; N: Node; TNM: Tumor Node Metastasis; CIP2A: Cancerous inhibitor of protein phosphatase 2A.

Citation: Zhao YX, Ma LB, Yang Z, Wang F, Wang HY, Dang JY. Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin. World J Gastrointest Oncol 2023; 15(2): 286-302
URL: https://www.wjgnet.com/1948-5204/full/v15/i2/286.htm
DOI: https://dx.doi.org/10.4251/wjgo.v15.i2.286